[go: up one dir, main page]

ES2554561A1 - New baculovirus-derived promoters with high activity in baculovirus-based expression systems - Google Patents

New baculovirus-derived promoters with high activity in baculovirus-based expression systems Download PDF

Info

Publication number
ES2554561A1
ES2554561A1 ES201430914A ES201430914A ES2554561A1 ES 2554561 A1 ES2554561 A1 ES 2554561A1 ES 201430914 A ES201430914 A ES 201430914A ES 201430914 A ES201430914 A ES 201430914A ES 2554561 A1 ES2554561 A1 ES 2554561A1
Authority
ES
Spain
Prior art keywords
baculovirus
expression systems
high activity
based expression
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201430914A
Other languages
Spanish (es)
Other versions
ES2554561B1 (en
Inventor
Salvador HERRERO SENDRA
Agata Karolina JAKUBOWSKA
María MARTÍNEZ SOLÍS
José Ángel Martínez Escribano
Silvia Gómez Sebastián
Javier López Vidal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alternative Gene Expression SL ALGENEX
Universitat de Valencia
Original Assignee
Alternative Gene Expression SL ALGENEX
Universitat de Valencia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alternative Gene Expression SL ALGENEX, Universitat de Valencia filed Critical Alternative Gene Expression SL ALGENEX
Priority to ES201430914A priority Critical patent/ES2554561B1/en
Publication of ES2554561A1 publication Critical patent/ES2554561A1/en
Application granted granted Critical
Publication of ES2554561B1 publication Critical patent/ES2554561B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/866Baculoviral vectors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención pertenece al campo de la biotecnología y comprende secuencias de ácidos nucleicos, incluyendo promotores capaces de incrementar la calidad y eficacia de la producción de proteínas recombinantes. Específicamente, la presente invención se refiere a una secuencia de ácido nucleico adecuada para funcionar como un promotor de baculovirus que comprende: a. la secuencia SEQ ID NO.: 1 ó su secuencia complementaria; o b. una variante de cualquiera de las secuencias del apartado a) que posee al menos un 70% de identidad con dicha secuencia.The present invention belongs to the field of biotechnology and comprises nucleic acid sequences, including promoters capable of increasing the quality and efficiency of recombinant protein production. Specifically, the present invention relates to a nucleic acid sequence suitable to function as a baculovirus promoter comprising: a. the sequence SEQ ID NO.: 1 or its complementary sequence; or b. a variant of any of the sequences in part a) that has at least 70% identity with said sequence.

ES201430914A 2014-06-16 2014-06-16 New baculovirus-derived promoters with high activity in baculovirus-based expression systems Expired - Fee Related ES2554561B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201430914A ES2554561B1 (en) 2014-06-16 2014-06-16 New baculovirus-derived promoters with high activity in baculovirus-based expression systems

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430914A ES2554561B1 (en) 2014-06-16 2014-06-16 New baculovirus-derived promoters with high activity in baculovirus-based expression systems

Publications (2)

Publication Number Publication Date
ES2554561A1 true ES2554561A1 (en) 2015-12-21
ES2554561B1 ES2554561B1 (en) 2016-09-30

Family

ID=54846299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201430914A Expired - Fee Related ES2554561B1 (en) 2014-06-16 2014-06-16 New baculovirus-derived promoters with high activity in baculovirus-based expression systems

Country Status (1)

Country Link
ES (1) ES2554561B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021236908A2 (en) 2020-05-20 2021-11-25 Biomarin Pharmaceutical Inc. Use of regulatory proteins for the production of adeno-associated virus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012168492A2 (en) * 2011-06-10 2012-12-13 Alternative Gene Expression S.L. Recombinant dna elements for the expression of recombinant proteins in a host cell
WO2014086981A1 (en) * 2012-12-07 2014-06-12 Alternative Gene Expression S.L. Baculovirus system for expressing proteins forming virus-like particles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012168492A2 (en) * 2011-06-10 2012-12-13 Alternative Gene Expression S.L. Recombinant dna elements for the expression of recombinant proteins in a host cell
WO2014086981A1 (en) * 2012-12-07 2014-06-12 Alternative Gene Expression S.L. Baculovirus system for expressing proteins forming virus-like particles

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HELDENS, J.G. et al., `A highly conserved genomic region in baculoviruses: sequence analysis of an 11.3 kbp DNA fragment (46.5-55.1 m.u.) of the Spodoptera exigua multicapsid nucleopolyhedrovirus¿, VIRUS RESEARCH, 1998, Vol. 55, No. 2, Págs 187-198, ISSN: 0168-1702, todo el documento. *
MILLÁN-LEIVA, A. et al., `Genome sequence of SeIV-1, a novel virus from the Iflaviridae family infective to Spodoptera exigua¿, JOURNAL OF INVERTEBRATE PATHOLOGY, 2012, Vol. 109, No. 1, Págs 127-133, ISSN: 0022-2011, doi: 10.1016/j.jip.2011.10.009, todo el documento. *
PASCUAL, L. et al., `The transcriptome of Spodoptera exigua larvae exposed to different types of microbes.¿, Insect BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2012, Vol. 42, No. 8, Págs 557-570, ISSN: 0965-1748 (print), ISSN: 1879-0240 (electronic), doi: 10.1016/j.ibmb.2012.04.003, todo el documento. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021236908A2 (en) 2020-05-20 2021-11-25 Biomarin Pharmaceutical Inc. Use of regulatory proteins for the production of adeno-associated virus

Also Published As

Publication number Publication date
ES2554561B1 (en) 2016-09-30

Similar Documents

Publication Publication Date Title
MY191210A (en) Novel promoter and uses thereof
BR112016029581A2 (en) genetically modified bacteria and methods of genetic modification of bacteria
BR112012011305A2 (en) use of a protein homologous to a meab protein to increase the enzymatic activity of a 3-hydroxycarboxylic acid mutase
ES2721309T3 (en) Composition for preparing tagatose and method for preparing tagatose from fructose
GT201300252A (en) ALFA GLUCOSIDASE MODIFIED ACID WITH ACCELERATED PROCESSING
EA201790505A1 (en) CONNECTION, AIMED ON IL-23A AND TNF-ALPHA, AND ITS APPLICATION
CL2018000671A1 (en) Expression of recombinant proteins in trichoplusia pupae or
BR112016016539A2 (en) carbohydrate enriched recombinant microorganisms
EA201691754A1 (en) RECOMBINANT MICROORGANISM, EXPRESSING ANALOG AVERMECTIN, AND ITS APPLICATION
AR100606A1 (en) VARIANTS OF LIPASES AND POLINUCLEOTIDES CODING THEM
BR112018009729A8 (en) method for producing a recombinant polypeptide, filamentous fungus myceliophthora thermophila and use of a nucleic acid construct
MX2016008258A (en) NEW EUCARIOT CELLS AND METHODS FOR THE RECOMBINANT EXPRESSION OF A PRODUCT OF INTEREST.
CL2018000164A1 (en) Recombinant vector of the orf virus.
PE20170185A1 (en) PHARMACEUTICAL COMPOSITIONS TO TREAT INFECTIOUS DISEASES
EA201890710A1 (en) METHOD FOR CLEANING BIOMASS HYDROLYSATE
BR112017005109A2 (en) refractory product based on al2o3, composition of raw materials for product manufacture, method for manufacturing refractory product, refractory product, and use of refractory product
BR112016019390A2 (en) fusion proteins uti
PE20151206A1 (en) POLYPEPTIDES OF SHORT ACTION FACTOR VII
CO2017006157A2 (en) Protein manufacturing method
BR112017024855A2 (en) aldc production methods
AR099810A1 (en) MICROORGANISMS THAT PRODUCE AMINO ACIDS L AND PROCESS TO PRODUCE AMINO ACIDS BY USING THEM
ES2554561A1 (en) New baculovirus-derived promoters with high activity in baculovirus-based expression systems
CL2017001383A1 (en) Process for the manufacture of carboxylic anhydride
MX2018009676A (en) Process.
CU20170036A7 (en) BLENDS THAT INCLUDE A PLURALITY OF POLYPEPTIDES WITH DEGRADING ACTIVITY OF BIOMASS AND METHODS TO PRODUCE THE SAME

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2554561

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20160930

FD2A Announcement of lapse in spain

Effective date: 20210929